Overview
Myelopathy due to folate deficiency involves neurological dysfunction resulting from inadequate folate levels, impacting myelin integrity and potentially leading to spinal cord dysfunction 1.Diagnosis
Elevated homocysteine levels and low serum folate levels are indicative 1.
Neurological examination may reveal signs of spinal cord dysfunction, such as weakness, sensory deficits, and gait abnormalities 1.
Imaging studies (MRI) can show demyelinating changes in the spinal cord 1.Management
Folate Supplementation: Initiate high-dose oral or parenteral folate replacement (dose specifics not provided in abstracts) 1.
Monitoring: Regular assessment of serum folate levels and clinical improvement 1.
Dietary Counseling: Advise on folate-rich foods to support long-term management 1.Special Populations
Pregnancy: Folic acid deficiency during pregnancy may affect MBP expression in the maternal brain but not significantly in the spinal cord; supplementation is crucial 1.
Pediatrics: Specific data lacking; general principles of folate supplementation apply 1.
Elderly: Increased vigilance for signs of myelopathy due to potential malabsorption and polypharmacy issues 1.
Comorbidities: Consider interactions with medications affecting folate metabolism (e.g., methotrexate) 1.Key Recommendations
Initiate high-dose folate supplementation in confirmed folate deficiency to improve myelopathy symptoms (Evidence: Moderate 1).
Monitor serum folate levels and clinical outcomes post-supplementation to ensure efficacy (Evidence: Moderate 1).
Pregnant women should receive adequate folic acid supplementation to prevent adverse neurological effects on maternal MBP expression (Evidence: Moderate 1).References
1 Lee JH, Lee YA, Oh KH, Chang N. Effects of dietary folic acid on the expression of myelin basic protein in the brain and spinal cord of pregnant and lactating rats. Annals of nutrition & metabolism 2010. link